Anticancer and radiosensitizing effects of the cyclin-dependent kinase inhibitors, AT7519 and SNS‑032, on cervical cancer

  • Authors:
    • Mi Ae Kang
    • Wonwoo Kim
    • Hye-Ram Jo
    • Young-Joo Shin
    • Moon-Hong Kim
    • Jae-Hoon Jeong
  • View Affiliations

  • Published online on: May 31, 2018     https://doi.org/10.3892/ijo.2018.4424
  • Pages: 703-712
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Cyclin-dependent kinases (CDK) are considered to be potential targets of anticancer drugs that can interrupt the uncontrolled division of cancer cells. In this study, we selected two selective CDK inhibitors, AT7519 and SNS‑032, from current clinical trials and examined their anticancer and radiosensitizing effects in a cervical cancer model. SNS‑032 was found to be more potent than AT7519, with a lower half maximal inhibitory concentration (IC50) value. Both AT7519 and SNS‑032 induced the apoptosis, premature senescence and cytostasis of cervical cancer cells, which led to the attenuation of tumor growth in vivo. Moreover, using these CDK inhibitors together with radiation synergistically inhibited tumor growth in a human xenograft tumor model. The concomitant activation of the p53 tumor suppressor and the suppression of cell cycle checkpoint responses mediated by Chk1 led to the cytostasis of cervical cancer cells. Finally, AT7519 and SNS‑032 inhibited cancer cell migration, invasion and angiogenesis in vitro, and suppressed lung metastases in a spontaneous metastasis model. On the whole, the findings of this study indicate that the utilization of AT7519 and SNS‑032 as part of an adjuvant treatment may help control cervical cancer progression.
View Figures
View References

Related Articles

Journal Cover

August-2018
Volume 53 Issue 2

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Kang MA, Kim W, Jo H, Shin Y, Kim M and Jeong J: Anticancer and radiosensitizing effects of the cyclin-dependent kinase inhibitors, AT7519 and SNS‑032, on cervical cancer. Int J Oncol 53: 703-712, 2018
APA
Kang, M.A., Kim, W., Jo, H., Shin, Y., Kim, M., & Jeong, J. (2018). Anticancer and radiosensitizing effects of the cyclin-dependent kinase inhibitors, AT7519 and SNS‑032, on cervical cancer. International Journal of Oncology, 53, 703-712. https://doi.org/10.3892/ijo.2018.4424
MLA
Kang, M. A., Kim, W., Jo, H., Shin, Y., Kim, M., Jeong, J."Anticancer and radiosensitizing effects of the cyclin-dependent kinase inhibitors, AT7519 and SNS‑032, on cervical cancer". International Journal of Oncology 53.2 (2018): 703-712.
Chicago
Kang, M. A., Kim, W., Jo, H., Shin, Y., Kim, M., Jeong, J."Anticancer and radiosensitizing effects of the cyclin-dependent kinase inhibitors, AT7519 and SNS‑032, on cervical cancer". International Journal of Oncology 53, no. 2 (2018): 703-712. https://doi.org/10.3892/ijo.2018.4424